A phase I/II clinical trial of autologous cytokine-induced killer cells as adjuvant immunotherapy for acute and chronic myeloid leukemia in clinical remission.

A phase I/II clinical trial of autologous cytokine-induced killer cells as adjuvant immunotherapy for acute and chronic myeloid leukemia in clinical remission.

Item
http://www.wikidata.org/entity/Q40280519
Selection and expansion of natural killer cells for NK cell-based immunotherapyCytokine-induced killer (CIK) cells in cancer immunotherapy: report of the international registry on CIK cells (IRCC).Immunotherapy of DC-CIK cells enhances the efficacy of chemotherapy for solid cancer: a meta-analysis of randomized controlled trials in Chinese patients.UV-inactivated HSV-1 potently activates NK cell killing of leukemic cells.Engineering antiphagocytic biomimetic drug carriers.Adoptive immunotherapy strategies with cytokine-induced killer (CIK) cells in the treatment of hematological malignanciesImmune checkpoint inhibitors enhance cytotoxicity of cytokine-induced killer cells against human myeloid leukaemic blasts.Immunoreceptor TIGIT inhibits the cytotoxicity of human cytokine-induced killer cells by interacting with CD155.Cytokine-induced killer cells: A novel immunotherapy strategy for leukemia.Bevacizumab improves the antitumor efficacy of adoptive cytokine-induced killer cells therapy in non-small cell lung cancer models.A comparison between cytokine- and bead-stimulated polyclonal T cells: the superiority of each and their possible complementary role.Adjuvant immunotherapy of dendritic cells and cytokine-induced killer cells is safe and enhances chemotherapy efficacy for multiple myeloma in China: a meta-analysis of clinical trials.Innovative Clinical Perspectives for CIK Cells in Cancer Patients.Successful alternative treatment for relapsed adult acute lymphoblastic leukemia with dendritic cells-cytokine-induced killer cells combined with a rituximab-based regimen
P2860

A phase I/II clinical trial of autologous cytokine-induced killer cells as adjuvant immunotherapy for acute and chronic myeloid leukemia in clinical remission.

Item
http://www.wikidata.org/entity/Q40280519
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
A phase I/II clinical trial of ...... eukemia in clinical remission.
@en
type
label
A phase I/II clinical trial of ...... eukemia in clinical remission.
@en
prefLabel
A phase I/II clinical trial of ...... eukemia in clinical remission.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
A phase I/II clinical trial of ...... eukemia in clinical remission.
@en
P2093
P304
P31
P356
10.3109/14653249.2012.694419
P433
P478
P50
P577
P698
P921